We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NICE Turns Down Janssen’s Stelara for Psoriatic Arthritis
NICE Turns Down Janssen’s Stelara for Psoriatic Arthritis
Janssen Pharmaceuticals’ psoriatic arthritis biologic Stelara is not a cost-effective option for adults who have not responded well to non-biological drugs used to slow down disease progression, say British health-payment authorities.